论文部分内容阅读
目的:分析血栓通注射液治疗外伤性玻璃体出血患者的临床疗效,以便为临床治疗提供参考。方法:选择在我院就诊的外伤性玻璃体出血患者70例,全部病例均进行血栓通注射液70 mg,1次/d局部离子导入。结果:治疗时间1~5个月,平均为(2.20±0.30)个月。全部70例患者,治愈60.00%,好转31.43%,无效8.57%,总有效率为91.43%。结论:采用血栓通注射液治疗外伤性玻璃体出血患者,具有较佳的疗效,建议临床进一步推广。
Objective: To analyze the clinical efficacy of Xueshuantong injection in traumatic vitreous hemorrhage in order to provide reference for clinical treatment. Methods: Seventy patients with traumatic vitreous hemorrhage treated in our hospital were selected. All the patients were treated with Xueshuantong injection 70 mg once a day. Results: The treatment time ranged from 1 to 5 months with an average of (2.20 ± 0.30) months. All 70 patients, 60.00% cured, improved 31.43%, invalid 8.57%, the total effective rate was 91.43%. Conclusion: Xueshuantong injection in traumatic vitreous hemorrhage patients with better efficacy, it is recommended to further promote the clinical.